US2021100746A1PendingUtilityA1

Method and devices for cellular transfer of compounds with augmented reality application

Assignee: DEFRANK NICOLASPriority: Oct 6, 2019Filed: Oct 6, 2019Published: Apr 8, 2021
Est. expiryOct 6, 2039(~13.2 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A23B 2/05C02F 2303/185C02F 2303/16C02F 2303/04C02F 2103/32C02F 2101/12C02F 1/686C02F 1/685C02F 1/66C02F 1/325C02F 1/283C02F 1/001A23V 2002/00A23L 2/80A23L 2/72A23L 2/68A23L 2/56A61Q 19/00A61Q 19/08A61Q 11/00A61Q 7/00A61K 8/14A61K 8/9794A61K 31/122A61K 9/0056A61K 31/726A61K 31/353A61K 9/127A61K 36/886A61K 9/006A61K 9/0014A61K 9/1277A61K 9/08A61K 31/05
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The embodiments disclose a method, including suspending cannabinoid compound molecules and constituents in an aqueous solution, suspending Aloe Vera molecules and its constituents in an aqueous solution, wherein a combination of cannabinoid compound molecules and constituents and Aloe Vera molecules and its constituents may be used for suspending in an aqueous solution, encapsulating cannabinoid compound molecules and Aloe Vera molecules within a liposome in an aqueous solution, and blending the liposome encapsulated cannabinoid compound molecules and Aloe Vera molecules with other ingredients into a health beneficial product and delivery system for oral including sublingual ingestion and nasal spray and suppository insertion or topical application with a plurality of nano sensors by humans.

Claims

exact text as granted — not AI-modified
1 . A method, comprising:
 suspending legal cannabinoid compound molecules and constituents selected for increasing health benefits of each selected constituent in water;   suspending Aloe Vera molecules and constituents selected for increasing health benefits of each selected constituent in water;   suspending Inflacin molecules in water;   encapsulating within a liposome at least one of a group comprising legal cannabinoid compound molecules and selected constituents, Aloe Vera compound molecules and selected constituents suspended, and Inflacin molecules suspended in water; and   blending at least one of a group comprising liposome encapsulated legal cannabinoid compound molecules and selected constituents, Aloe Vera molecules and selected constituents, and Inflacin molecules into beneficial cellular transfer products and cellular transfer delivery systems for human use.   
     
     
         2 . The method of  claim 1 , further comprising using a cellular transfer augmented reality application for providing users with a real time simulation of cellular transfer physical results of cellular transfer products. 
     
     
         3 . The method of  claim 1 , further comprising suspending legal cannabinoid compound molecules including cannabidiol and cannabigerol and selected constituents. 
     
     
         4 . The method of  claim 1 , further comprising suspending legal cannabinoid compound molecules and its selected constituents in water including Cannabidiol and cannabigerol. 
     
     
         5 . The method of  claim 1 , further comprising suspending legal cannabinoid compound molecules and selected constituents in water. 
     
     
         6 . The method of  claim 1 , further comprising suspending Aloe Vera molecules and its selected constituents in water including phytochemical constituents. 
     
     
         7 . The method of  claim 1 , further comprising suspending Aloe Vera molecules and its selected constituents in water including emodin, aloesin, and acemannan. 
     
     
         8 . The method of  claim 1 , further comprising encapsulating legal cannabinoid compound molecules and selected constituents and Aloe Vera molecules and selected constituents within a liposome in water may be configured to include varying proportions of separately encapsulated legal cannabinoid compound molecules and selected constituents and Aloe Vera molecules and selected constituents for increasing health benefits of each for a specific purpose for a specific health condition. 
     
     
         9 . The method of  claim 1 , further comprising blending the liposome encapsulated legal cannabinoid compound molecules and selected constituents and Aloe Vera molecules and selected constituents into a cellular transfer beneficial product and delivery system for oral ingestion including sublingual ingestion by humans. 
     
     
         10 . The method of  claim 1 , further comprising blending the liposome encapsulated legal cannabinoid compound molecules and selected constituents and Aloe Vera molecules and selected constituents with other ingredients into a healthy beneficial product and delivery system for topical applications by humans. 
     
     
         11 - 20 . (canceled)

Join the waitlist — get patent alerts

Track US2021100746A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.